Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumours

Daniel M. Huse, Margaret Von Mehren, Gregory Lenhart, Heikki Joensuu, Charles Blanke, Weiwei Feng, Stan Finkelstein, George Demetri

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumours'. Together they form a unique fingerprint.

Medicine & Life Sciences